There are currently no medications that can slow down the common form of arthritis that strikes aging knees and hips. But a new study suggests a powerful, and expensive, anti-inflammatory drug could potentially do just that.
The drug, called canakinumab (Ilaris), is used for certain rare rheumatic conditions marked by widespread inflam... Full Page
Physically fit patients with the irregular heartbeat atrial fibrillation (AF) are most likely to benefit from ablation, a new study finds.
Patients who are less fit are hospitalized more often, continue to use anti-arrhythmic drugs longer and have higher death rates, researchers say.
"AF does not occur in a vacuum but rathe... Full Page
Health News is provided as a service to Seip Drug site users by HealthDay. Seip Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.